Role of the C-terminal domain of PCSK9 in degradation of the LDL receptorsØystein L. Holla, Trond P. Leren, Jamie Cameron et al.|Journal of Lipid Research|2011Cited by 63
Interaction between the ligand-binding domain of the LDL receptor and the C-terminal domain of PCSK9 is required for PCSK9 to remain bound to the LDL receptor during endosomal acidificationKristian Tveten, Trond P. Leren, Jon K. Laerdahl et al.|Human Molecular Genetics|2011Cited by 61
4‐Phenylbutyrate restores the functionality of a misfolded mutant low‐density lipoprotein receptorKristian Tveten, Mari Ann Kulseth, Knut Erik Berge et al.|FEBS Journal|2007Cited by 59
PCSK9-mediated degradation of the LDL receptor generates a 17 kDa C-terminal LDL receptor fragmentKristian Tveten, Trond P. Leren, Thea Bismo Str⊘m et al.|Journal of Lipid Research|2013Cited by 37
Serum levels of proprotein convertase subtilisin/kexin type 9 in subjects with familial hypercholesterolemia indicate that proprotein convertase subtilisin/kexin type 9 is cleared from plasma by low-density lipoprotein receptor–independent pathwaysJamie Cameron, Trond P. Leren, Kirsten B. Holven et al.|Translational research|2012Cited by 36